PUMA BIOTECHNOLOGY, INC. Contracts & Agreements

90 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
THIRD AMENDMENT TO LEASE
Lease Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2015
Sixth Amendment to Puma Biotechnology, Inc. 2011 Incentive Award Plan
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
2024
Seventh Amendment to Note Purchase Agreement and Third Amendment to Disclosure Letter, dated April 12, 2024, by and between the Company and Athyrium Opportunities IV CO-Invest 1...
Note Agreements
PUMA BIOTECHNOLOGY, INC.
2024
Sixth Amendment to Note Purchase Agreement, dated September 8, 2023, by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent
Note Agreements
PUMA BIOTECHNOLOGY, INC.
2023
Limited Waiver and Fifth Amendment to Note Purchase Agreement, dated July 7, 2023, by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent
Note Agreements
PUMA BIOTECHNOLOGY, INC.
2023
Second Amendment to Note Purchase Agreement, dated May 18, 2022,by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent
Note Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2023
Fourth Amendment to Note Purchase Agreement, dated November29, 2022,by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent
Note Agreements
PUMA BIOTECHNOLOGY, INC.
2023
Securities Purchase Agreement, dated December 9, 2022, by and between Puma Biotechnology, Inc. and Alan H. Auerbach
Purchase Agreements
PUMA BIOTECHNOLOGY, INC.
2022
Third Amendment to Note Purchase Agreement, dated September 16, 2022, by and between the Company and Athyrium Opportunities IV Co-Invest 1 LP, as Administrative Agent
Note Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2022
Exclusive License Agreement, dated September 16, 2022, by and between the Company and Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company...
License Agreements
PUMA BIOTECHNOLOGY, INC.
2022
First Amendment to Note Purchase Agreement, dated February 8, 2022, by and between the Company and Athyrium Opportunities IV CO-Invest 1 LP, as Administrative Agent
Note Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2022
Open Market Sale AgreementSM, dated November 4, 2021, by and between Puma Biotechnology, Inc. and Jefferies LLC
PUMA BIOTECHNOLOGY, INC.
2021
Amendment to Warrant to Purchase Shares of Common Stock of Puma Biotechnology, Inc
Warrant Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2021
Fifth Amendment to Puma Biotechnology, Inc. 2011 Incentive Award Plan
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2021
Fourth Amendment to Amended and Restated Loan and Security Agreement, dated February 3, 2021, by and between the Company and Oxford Finance LLC, as collateral agent and Lender
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2021
Termination Agreement, dated February 24, 2021, by and between the Company and CANbridge BIOMED Limited
Termination Agreements
PUMA BIOTECHNOLOGY, INC.
2021
Amendment No. 3 to the License Agreement, dated February 24, 2021, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
2021
Amendment No. 2 to License Agreement dated October 29, 2020, between the Company and Pfizer Inc
License Agreements
PUMA BIOTECHNOLOGY, INC.
2021
Letter Agreement, dated February 13, 2020, by and between the Company and Jeff J. Ludwig
PUMA BIOTECHNOLOGY, INC.
2021
Pfizer Letter Agreement dated June 8, 2020, by and between the Company and Pfizer Inc
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
Second Amendment to Amended and Restated Loan and Security Agreement, dated July 6, 2020, by and between the Company and Oxford Finance LLC, as collateral agent and Lender
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
2020
Third Amendment to Amended and Restated Loan and Security Agreement, dated August 5, 2020, by and between the Company and Oxford Finance LLC, as collateral agent and Lender
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
2020
Amended Non-Employee Director Compensation Program
Compensation Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
First Amendment to Amended and Restated Loan and Security Agreement, dated February 27, 2020, by and between the Company and Oxford Finance LLC, as collateral agent and Lender
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
Description of the Company's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
Amendment to the License Agreement, dated December 18, 2019, by and between the Company and Knight Therapeutics, Inc
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
First Amendment to the License Agreement, dated September 17, 2019, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2020
Second Amendment to the License Agreement, dated November 25, 2019, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
2020
Amended Non-Employee Director Compensation Program
Compensation Agreements
PUMA BIOTECHNOLOGY, INC.
2019
Amended and Restated Loan and Security Agreement, dated June 28, 2019, by and between the Company and Oxford Finance LLC, as collateral agent and lender
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2019
License Agreement, dated March 29, 2019, by and between the Company and Pierre Fabre Medicament SAS
License Agreements
PUMA BIOTECHNOLOGY, INC.
2019
Form of Stock Option Grant Notice and Stock Option Agreement, issued pursuant to the 2017 Employment Inducement Incentive Award Plan
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
DE
2019
Side Letter Agreement, dated November 19, 2018, between the Company and CANbridge Biomed Limited (as successor in interest to CANbridgepharma Limited)
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2019
License Agreement, dated January 9, 2019, by and between the Company and Knight Therapeutics Inc
License Agreements
PUMA BIOTECHNOLOGY, INC.
2019
Form Transition and General Release Agreement by and between Puma Biotechnology, Inc. and Charles R. Eyler
Transition Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2019
Employment Offer Letter, by and between Puma Biotechnology, Inc. and Maximo F. Nougues
Employment Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2018
Second Amendment to Loan and Security Agreement, dated September 27, 2018, by and among the Company, Silicon Valley Bank, as administrative and collateral agent and lender, and...
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
2018
First Amendment to Loan and Security Agreement, dated May 8, 2018, by and among the Company, Silicon Valley Bank, as administrative and collateral agent
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
2018
Amendment No. 1, dated April 20, 2018, to the License Agreement by and between the Company and Specialised Therapeutics Asia Pte Ltd
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2018
Supply Agreement, dated April 20, 2018, by and between the Company and Specialised Therapeutics Asia Pte. Ltd
Supply Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2018
Amended Non-Employee Director Compensation Program
Compensation Agreements
PUMA BIOTECHNOLOGY, INC.
2018
Collaboration and License Agreement, dated January 30, 2018, between the Company and CANbridgepharma Limited
Collaboration Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CT
2018
License Agreement, dated March 30, 2018, between the Company and Pint Pharma International SA
License Agreements
PUMA BIOTECHNOLOGY, INC.
2018
License Agreement, dated November 20, 2017, by and between the Company and Specialised Therapeutics Asia Pte Ltd
License Agreements
PUMA BIOTECHNOLOGY, INC.
2018
Loan and Security Agreement dated October 31, 2017, by and among the Company, Silicon Valley Bank, as administrative and collateral agent, and the lenders party thereto from time...
Loan Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2018
Letter Agreement, dated December 8, 2017, between the Company and Douglas Hunt
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2018
Puma Biotechnology, Inc. Non-Employee Director Compensation Program
Compensation Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2017
THIRD AMENDMENT TO PUMABIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
2017
FOURTH AMENDMENT TO PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
2017
PUMA BIOTECHNOLOGY, INC. (aDelaware corporation) 3,750,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2016
PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
2016
10880 Wilshire Blvd. Suite 2150 Los Angeles, CA 90024 ###-###-#### Phone ###-###-#### Fax
PUMA BIOTECHNOLOGY, INC.
2016
10880 Wilshire Blvd. Suite 2150 Los Angeles, CA 90024 ###-###-#### Phone ###-###-#### Fax
PUMA BIOTECHNOLOGY, INC.
2016
Puma Biotechnology, Inc. Non-Employee Director Compensation Program (Effective January 21, 2016)
Compensation Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2016
FOURTH AMENDMENT
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2015
10880 Wilshire Blvd. Suite 2150 Los Angeles, CA 90024 ###-###-#### Phone ###-###-#### Fax
PUMA BIOTECHNOLOGY, INC.
2015
SECOND AMENDMENT TO PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
2015
SECOND AMENDMENT TO LEASE
Lease Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2015
THIRD AMENDMENT
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2015
PUMA BIOTECHNOLOGY, INC. (a Delaware corporation) 1,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2015
Amendment No. 1 to License Agreement between Puma Biotechnology, Inc. and Pfizer Inc.
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2014
FIRST AMENDMENT TO LEASE
Lease Agreements
PUMA BIOTECHNOLOGY, INC.
2014
PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN PERFORMANCE SHARE AWARD GRANT NOTICE
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
DE
2014
SECOND AMENDMENT
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2014
PUMA BIOTECHNOLOGY, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM
Compensation Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
2014
FIRST AMENDMENT
PUMA BIOTECHNOLOGY, INC.
2013
PUMA BIOTECHNOLOGY, INC. (a Delaware corporation) 7,500,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
PUMA BIOTECHNOLOGY, INC.
2012
PUMA BIOTECHNOLOGY, INC. (a Delaware corporation) lShares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2012
INDEMNIFICATION AGREEMENT
Indemnification Agreements
PUMA BIOTECHNOLOGY, INC.
2012
10880 Wilshire Blvd. Suite 2150 Los Angeles,California 90024 ###-###-#### Phone ###-###-#### Fax
PUMA BIOTECHNOLOGY, INC.
2012
OFFICE LEASE BY AND BETWEEN DWF III GATEWAY, LLC, A Delaware limited liability company, As Landlord And PUMA BIOTECHNOLOGY, INC., A Delaware corporation, as Tenant For Leased...
Lease Agreements
PUMA BIOTECHNOLOGY, INC.
2012
PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
2012
PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE AND STOCK OPTION AGREEMENT
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
2012
EMPLOYMENT AGREEMENT
Employment Agreements
PUMA BIOTECHNOLOGY, INC.
2012
LICENSE AGREEMENT
License Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011
PUMA BIOTECHNOLOGY, INC. REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011
OFFICE LEASE
Lease Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2011
PUMA BIOTECHNOLOGY, INC. SUBSCRIPTION AGREEMENT
Subscription Agreements
PUMA BIOTECHNOLOGY, INC.
2011
AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
PUMA BIOTECHNOLOGY, INC.
2011
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
PUMA BIOTECHNOLOGY, INC.
2011
PUMA BIOTECHNOLOGY, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK
Warrant Agreements
PUMA BIOTECHNOLOGY, INC.
2011
PUMA BIOTECHNOLOGY, INC. WARRANT TO PURCHASE SHARES OF COMMON STOCK
Warrant Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
CA
2011
LICENSE AGREEMENT
License Agreements
PUMA BIOTECHNOLOGY, INC.
2011
REDEMPTION AGREEMENT
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011
PUMA BIOTECHNOLOGY, INC. 2011 INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE
Bonus & Incentive Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
DE
2011
PUMA BIOTECHNOLOGY, INC. REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
PUMA BIOTECHNOLOGY, INC.
2011
AGREEMENT AND PLAN OF MERGER by and among Puma Biotechnology, Inc. Innovative Acquisitions Corp. and IAC Merger Corporation September 29, 2011 TABLE OF CONTENTS
Merger Agreements
PUMA BIOTECHNOLOGY, INC.
Biotechnology
DE
2011
INDEMNITY AGREEMENT
PUMA BIOTECHNOLOGY, INC.
Biotechnology
NY
2011